AARD
Aardvark Therapeutics, Inc. · Healthcare
Cormorant Asset Management, LP bought $3.0M of Aardvark Therapeutics, Inc.
Former 10% Owner
Bought$3,000,000
$16.00Price
187,500Shares
+23%Stake
What AARD did for a copier
- $1,000 copied at Wed, Feb 19 close, $14.90
- $628
- S&P 500, same days
- −7.6%
Measured over 30 trading days, to the Apr 2 close.
Cormorant Asset Management, LP's record
16 other buys with 3 months of prices since 2016: on average −4.9% against the S&P 500, and 8 of 16 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Fri, Feb 14. Filed Wed, Feb 19, 11:02 AM ET, during the session. Returns use the Feb 19 close and the Apr 2 close. Not investment advice.